What Medicus Pharma Ltd's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 5 | 5 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 5 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Smith Andrew Alasdair | Chief Operating Officer | Sep 04 | Grant / award · A | +735,294 | $0.17 | +$125K | 735,458 |
| Mehmud Faisal | Chief Medical Officer | Sep 04 | Grant / award · A | +1,470,588 | $0.17 | +$251K | 1,470,588 |
| Bonner Carolyn F. | President and CFO | Sep 04 | Grant / award · A | +1,470,588 | $0.17 | +$251K | 1,489,493 |
| Bokhari Raza | Chief Executive Officer | Sep 04 | Grant / award · A | +2,941,176 | $0.17 | +$501K | 2,941,176 |
| Brennan Edward J. | Chief Scientific Officer | Sep 04 | Grant / award · A | +588,235 | $0.17 | +$100K | 674,735 |
| Quinlan James P. | Chief Financial Officer | Aug 13 | Exercise / conversion · M | +20,000 | $2.75 | +$55K | 274,147 |
| Quinlan James P. | Chief Financial Officer | Aug 13 | Exercise / conversion · M | +125,000 | $0.81 | +$101K | 254,147 |
| Velocity Fund PARTNERS, Lp | 10% owner | May 20 | Open-market sale · S | −75,000 | $7.72 | −$579K | 3,248,741 |
Loading...
